Milestone Pharmaceuticals
MIST | NASDAQ
$0.36
-$0.16 (-30.77%)
At close: Nov 16, 2026, 4:00 PM ET
$0.39
+$0.03 (+8.06%)
After-hours:
Nov 16, 2026, 7:58 PM ET
-30.77%
(1D)No price chart data available for 1D timeframe.
Rating
37.5
-1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #597/1021 (Top 58%)
Key Statistics
Market Data
Market Cap $50.73M
1D Range
0.36 0.52
52W Range
0.36 2.95
Valuation (TTM)
PE -0.48
PB -8.16
EV/EBITDA 0.39
Valuation (NTM)
Forward PE N/A
Forward PEG -0.06
Price Target $3.00
Cash Flow
FCF Yield -150.1%
SBC Adj. FCF Yield -171.9%
SBC Impact -14.5%
Margins
Gross Margin 92.0%
Operating Margin -1728.4%
FCF Margin -1435.3%
Growth (CAGR)
Revenue 3Y | 5Y 5.7% |
-18.8%
Dil EPS 3Y | 5Y 9.1% |
18.4%
FCF 3Y | 5Y -44.0% |
-8.2%
Returns
ROA -60.2%
ROE -435.9%
ROIC -66.6%
Financial Health
Net Cash
$85.12M
Current Ratio 6.27
Interest Coverage -7.63
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etri...
Sector Healthcare
Industry Biotechnology
Employees 38
IPO Date May 9, 2019
Website www.milestonepharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.18
Beat +16.55%
YoY:
-50.00% REV
$2.96M
Beat +196.30%
Next Earnings
Mar 19, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$3.00
Upside
+733.33%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MIST